Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis

Published:2019-04-03 Issue:4 Volume:54 Page:407-413
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Ribaldone Davide Giuseppe¹,Pellicano Rinaldo²,Vernero Marta³,Caviglia Gian Paolo⁴^ORCID,Saracco Giorgio Maria⁴,Morino Mario¹,Astegiano Marco²

Affiliation:

1. Department of Surgical Sciences, University of Turin, Turin, Italy;

2. Molinette Hospital, Unit of Gastroenterology, Turin, Italy;

3. First Department of Internal Medicine, IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;

4. Department of Medical Sciences, University of Turin, Turin, Italy

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2019.1597159

Reference18 articles.

1. Review article: remission rates achievable by current therapies for inflammatory bowel disease

2. A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms

3. Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders

4. Combination of Biologic Agents in the Management of Severe Refractory Crohnʼs Disease: A Case Report of Concomitant Treatment with Vedolizumab and Adalimumab

5. Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease;World Journal of Gastroenterology;2024-07-07

2. Diagnosis and management of inflammatory bowel disease;Journal of Evidence-Based Medicine;2024-06

3. Challenges in IBD Research 2024: Pragmatic Clinical Research;Inflammatory Bowel Diseases;2024-05-01

4. Combination treatment of inflammatory bowel disease: Present status and future perspectives;World Journal of Gastroenterology;2024-04-21

5. Efficacy and safety of dual therapy - biological and small molecules in patients with ulcerative colitis;Experimental and Clinical Gastroenterology;2024-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3